No side effects were observed.<h4>Conclusions</h4>In some severe allergic asthma patients with persistently high eosinophil counts in peripheral blood and who are considered non- or mild responders to anti-IgE and anti-IL5 administered individually, a combination of the two antibodies covering the entire T2 spectrum may be effective. The gene discussed is IGHE; the disease is allergic asthma.